homocysteine and Parkinsonian Disorders

homocysteine has been researched along with Parkinsonian Disorders in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's6 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhattacharya, P; Borah, A; Dutta, A; Justin-Thenmozhi, A; Manivasagam, T; Mazumder, MK; Paul, R; Phukan, BC1
Bhattacharjee, N; Borah, A; Choudhury, A; Choudhury, S; Mazumder, MK; Paul, R1
Bian, L; Chen, X; Jiang, Y; Long, L; Wang, Q; Xu, Y; Yan, J; Yang, L; Zhang, L; Zhu, C1
DiFrancisco-Donoghue, J; Elokda, A; Fazzini, E; Lamberg, EM; Rabin, E; Werner, WG1
Ataie, A; Mansouri, Z; Masoudnia, F; Moradi, F; Sabetkasaei, M1
Faraji, A; Fraidouni, N; Haghdoost-Yazdi, H; Jahanihashemi, H; Sarookhani, M1
Louis, ED; Luchsinger, JA; Marder, K; Schupf, N; Tang, MX1

Trials

1 trial(s) available for homocysteine and Parkinsonian Disorders

ArticleYear
Effects of exercise and B vitamins on homocysteine and glutathione in Parkinson's disease: a randomized trial.
    Neuro-degenerative diseases, 2012, Volume: 10, Issue:1-4

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Exercise Therapy; Female; Glutathione; Glutathione Disulfide; Homocysteine; Humans; Male; Middle Aged; Parkinsonian Disorders; Treatment Outcome; Vitamin B Complex

2012

Other Studies

6 other study(ies) available for homocysteine and Parkinsonian Disorders

ArticleYear
Accumulation of Cholesterol and Homocysteine in the Nigrostriatal Pathway of Brain Contributes to the Dopaminergic Neurodegeneration in Mice.
    Neuroscience, 2018, 09-15, Volume: 388

    Topics: Animals; Cholesterol; Corpus Striatum; Diet; Dopaminergic Neurons; Homocysteine; Hypercholesterolemia; Male; Mice; Motor Activity; Nerve Degeneration; Neural Pathways; Parkinsonian Disorders; Substantia Nigra

2018
L-DOPA treatment in MPTP-mouse model of Parkinson's disease potentiates homocysteine accumulation in substantia nigra.
    Neuroscience letters, 2016, 08-15, Volume: 628

    Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Homocysteine; Levodopa; Male; Mice; Motor Activity; Parkinsonian Disorders; Substantia Nigra; Tyrosine 3-Monooxygenase

2016
The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson's disease and vascular parkinsonism.
    PloS one, 2011, Apr-27, Volume: 6, Issue:4

    Topics: Adult; Aged; C-Reactive Protein; China; Cross-Sectional Studies; Female; Homocysteine; Humans; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Vascular Diseases

2011
Curcumin has neuroprotection effect on homocysteine rat model of Parkinson.
    Journal of molecular neuroscience : MN, 2012, Volume: 47, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Brain; Curcumin; Disease Models, Animal; Drug Interactions; Homocysteine; Male; Neuroprotective Agents; Parkinsonian Disorders; Rats; Rats, Wistar

2012
High intake of folic acid or complex of B vitamins provides anti-Parkinsonism effect: no role for serum level of homocysteine.
    Behavioural brain research, 2012, Aug-01, Volume: 233, Issue:2

    Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Apomorphine; Area Under Curve; Disease Models, Animal; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Folic Acid; Homocysteine; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Statistics, Nonparametric; Stereotyped Behavior; Vitamin B Complex

2012
Mild parkinsonian signs and plasma homocysteine concentration in community-dwelling elderly individuals.
    Archives of neurology, 2007, Volume: 64, Issue:11

    Topics: Aged; Aged, 80 and over; Cohort Studies; Community Health Planning; Cross-Sectional Studies; Dementia; Female; Geriatric Assessment; Homocysteine; Humans; Male; Mass Spectrometry; Neurologic Examination; Neuropsychological Tests; Parkinsonian Disorders; Residence Characteristics

2007